Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation

With rising COVID-19 infections to well above 20 million patients and north of 778,000 deaths across the world, a notable rising trend in psychiatric disorders, such as anxiety and depression, was concurrently observed. In tandem with continued research on preventive and therapeutic interventions to combat COVID-19, a renewed spotlight has been shed on strengthening host […]

Despite a growing body of research probing the use of omega-3 fatty acids (abundant in fish) in borderline personality disorder (BPD), a lack of clarity remains on their impact on disease outcomes. Through their work, Karaszewska et al. (2021) attempted to appraise the impact of using omega-3 fatty acids in BPD through meta-analyses employing an […]